In the another studies conduced by Thethi et al. showed that daily receiving 1 mcg paricalcitol orally for 12 weeks had no significant effect on TNF-a and IL-6 levels in patients with type 2 diabetes and chronic kidney disease. The gene discussed is IL6; the disease is chronic kidney disease.